1-4 of 4
Rituparna Chetia
Close
Sort by
Journal Articles

Comparison of Dexamethasone Versus Prednisolone Prephase in Induction Therapy of Pediatric Acute Lymphoblastic Leukemia: A Single-Center, Randomized Controlled Study from India

Anamika Bakliwal, Jatin Munjal, Rituparna Chetia, Debranjani Chattopadhyay, Sudeep Vaniyath, Ashok K Rajoreya, Uttam Kumar Nath
Journal: Blood
Blood (2022) 140 (Supplement 1): 11857–11859.
https://doi.org/10.1182/blood-2022-168919
Published: 2022
Journal Articles

Balancing the Bleeding Risk & Treatment Related Complications in Immune Thrombocytopenia - an Unmet Need: Real-World Data from India

Debranjani Chattopadhyay, Anamika Bakliwal, Sudeep Vaniyath, Rituparna Chetia, Gaurav Dhingra, Prof. Uttam Kumar Nath
Journal: Blood
Blood (2022) 140 (Supplement 1): 11257–11258.
https://doi.org/10.1182/blood-2022-171185
Published: 2022
Journal Articles

Encouraging Results with ALL IC-BFM 2009 Protocol Therapy in Pediatric Acute Lymphoblastic Leukemia/Lymphoma in Resource-Limited Setting: A Single-Center Study from India

Uttam Kumar Nath, MDDM, Debranjani Chattopadhyay, MD, Anamika Bakliwal, MD, Sudeep Vaniyath, MD, Rituparna Chetia, MD, Ashok K Rajoreya, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5118.
https://doi.org/10.1182/blood-2019-127985
Published: 2019
Journal Articles

Early Molecular Response with Generic Imatinib Therapy in Sokal/Hasford Intermediate- & High-Risk Chronic Phase Chronic Myeloid Leukemia Patients: A Single Institution Experience from India

Uttam Kumar Nath, MDDM, Rituparna Chetia, MD, Avriti Baveja, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4276.
https://doi.org/10.1182/blood-2018-99-110523
Published: 2018